Zacks Research Has Negative Estimate for Danaher Q3 Earnings

Key Points

• Zacks Research has revised Danaher Corporation's Q3 2025 earnings estimate down from $1.79 to $1.71 per share, amid a consensus full-year estimate of $7.63.
• Institutional investors have shown significant interest, with hedge funds owning 79.05% of the company's stock, reflecting growing investment confidence.
• Danaher recently reported better-than-expected earnings of $1.80 per share for the last quarter, surpassing analyst estimates by $0.16.

Danaher Corporation (NYSE:DHR - Free Report) - Investment analysts at Zacks Research decreased their Q3 2025 earnings per share estimates for shares of Danaher in a research note issued to investors on Tuesday, August 12th. Zacks Research analyst R. Department now anticipates that the conglomerate will earn $1.71 per share for the quarter, down from their previous estimate of $1.79. The consensus estimate for Danaher's current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher's Q4 2025 earnings at $2.37 EPS, FY2025 earnings at $7.75 EPS, Q2 2026 earnings at $1.93 EPS, Q3 2026 earnings at $2.00 EPS, Q4 2026 earnings at $2.60 EPS, FY2026 earnings at $8.52 EPS, Q1 2027 earnings at $2.07 EPS and FY2027 earnings at $9.27 EPS.

Other equities research analysts have also recently issued research reports about the company. Evercore ISI cut their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft cut their price target on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Wells Fargo & Company cut their price target on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. The Goldman Sachs Group cut their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Finally, Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective on the stock in a research note on Friday, July 11th. Three equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

Danaher Trading Up 3.0%

NYSE:DHR opened at $205.79 on Wednesday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $198.95 and its two-hundred day moving average is $200.34. Danaher has a 52 week low of $171.00 and a 52 week high of $279.90. The company has a market cap of $147.36 billion, a PE ratio of 43.79, a P/E/G ratio of 2.79 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.72 EPS.

Hedge Funds Weigh In On Danaher

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. boosted its stake in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter valued at $27,000. Sierra Ocean LLC boosted its stake in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the period. Red Tortoise LLC boosted its stake in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after buying an additional 98 shares during the period. Finally, Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher during the 1st quarter valued at $31,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.